A Review of the Pharmacological Properties of Insulin Degludec and Their Clinical Relevance

Por Haahr, Hanne, Heise, Tim
Publicado em 2014

Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes

Por Heise, Tim, Mathieu, Chantal
Publicado no Diabetes Obes Metab (2016)

Inhaled Insulin: Take a Deep Breath, but How?

Por Heinemann, Lutz, Scheuch, Gerhard, Heise, Tim
Publicado em 2008

A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use

Por Haahr, Hanne, Fita, Edmond G., Heise, Tim
Publicado no Clin Pharmacokinet (2016)

Common Standards of Basal Insulin Titration in T2DM

Por Arnolds, Sabine, Heise, Tim, Flacke, Frank, Sieber, Jochen
Publicado em 2013

Inhaled Technosphere® Insulin in Comparison to Subcutaneous Regular Human Insulin: Time Action Profile and Variability in Subjects with Type 2 Diabetes

Por Rave, Klaus, Heise, Tim, Heinemann, Lutz, Boss, Anders H.
Publicado em 2008

How to Assess the Quality of Glucose Clamps? Evaluation of Clamps Performed With ClampArt, a Novel Automated Clamp Device

Por Benesch, Carsten, Heise, Tim, Klein, Oliver, Heinemann, Lutz, Arnolds, Sabine
Publicado no J Diabetes Sci Technol (2015)

Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, doub...

Por Heise, Tim, Zijlstra, Eric, Nosek, Leszek, Rikte, Tord, Haahr, Hanne
Publicado no Diabetes Obes Metab (2016)

A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes

Por Heise, Tim, Pieber, Thomas R., Danne, Thomas, Erichsen, Lars, Haahr, Hanne
Publicado no Clin Pharmacokinet (2017)

Automated Near-Continuous Glucose Monitoring Measured in Plasma Using Mid-Infrared Spectroscopy

Por Jax, Thomas, Heise, Tim, Nosek, Leszek, Gable, Jennifer, Lim, Gene, Calentine, Christopher
Publicado em 2011

Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus

Por Heise, Tim, Nosek, Leszek, Roepstorff, Carsten, Chenji, Suresh, Klein, Oliver, Haahr, Hanne
Publicado em 2014

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes

Por Kapitza, Christoph, Zijlstra, Eric, Heinemann, Lutz, Castelli, M. Cristina, Riley, Gary, Heise, Tim
Publicado em 2010

Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus

Por Polidori, David, Sha, Sue, Ghosh, Atalanta, Plum-Mörschel, Leona, Heise, Tim, Rothenberg, Paul
Publicado em 2013

A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile than Insulin Glargine: Results from Continuous Glucose Monitorin...

Por Liebl, Andreas, Davidson, Jaime, Mersebach, Henriette, Dykiel, Patrik, Tack, Cees J., Heise, Tim
Publicado em 2013

A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

Por Heise, Tim, Hövelmann, Ulrike, Zijlstra, Eric, Stender-Petersen, Kirstine, Jacobsen, Jacob Bonde, Haahr, Hanne
Publicado no Drugs Aging (2016)

Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions

Por Hövelmann, Ulrike, Heise, Tim, Nosek, Leszek, Sassenfeld, Bettina, Thomsen, Karen Margrete Due, Haahr, Hanne
Publicado no Clin Drug Investig (2017)

Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial

Por Martin, Stephan, Herder, Christian, Schloot, Nanette C., Koenig, Wolfgang, Heise, Tim, Heinemann, Lutz, Kolb, Hubert
Publicado em 2011

Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy

Por Heise, Tim, Heinemann, Lutz, Hövelmann, Ulrike, Brauns, Bianca, Nosek, Leszek, Haahr, Hanne L., Olsen, Klaus J.
Publicado em 2009

The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)

Por Kolb, Hubert, Lückemeyer, Kathrin, Heise, Tim, Herder, Christian, Schloot, Nanette C., Koenig, Wolfgang, Heinemann, Lutz, Martin, Stephan
Publicado em 2013

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

Por Heise, Tim, Seman, Leo, Macha, Sreeraj, Jones, Peter, Marquart, Alexandra, Pinnetti, Sabine, Woerle, Hans J., Dugi, Klaus
Publicado em 2013